Ísrael - enska - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose anhydrous; lactic acid; magnesium chloride hexahydrate; potassium chloride; sodium chloride; sodium hydrogen carbonate - solution for heamodialysis/haemofiltration - calcium chloride dihydrate 5.145 g/l; magnesium chloride hexahydrate 2.033 g/l; glucose anhydrous 22.00 g/l; lactic acid 5.400 g/l; sodium chloride 6.45 g/l; sodium hydrogen carbonate 3.090 g/l; potassium chloride 0.314 g/l - combinations - prismasol 4 mmol/l potassium is used in the treatment of renal failure, as substitution solution in haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis or continuous haemodiafiltration. prismasol 4 mmol/l potassium solution may also be used in case of drug poisoning with dialysable or filterable substances. prismasol 4 mmol/l potassium solution is indicated in patients who are normokalaemic.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 6 g/l; olive oil, quantity: 24 g/l - injection, intravenous infusion - excipient ingredients: nitrogen; water for injections; sodium hydroxide; egg lecithin; sodium oleate; glycerol - olimel/periolimel is indicated for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - metoclopramide hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; water for injections; nitrogen; sodium chloride - adults (20 years or older): - relief of nausea and vomiting associated with migraine, cancer therapy (chemotherapy or radiation), malignant disease, labour, infectious disease and uraemia. - control of post-operative vomiting - assist in small bowel intubation.,metoclopramide is of little benefit for the prevention or treatment of motion sickness.,young adults and children (over 1 year of age): metoclopramide should be restricted to the following conditions and only used as second line therapy, when used to treat children and young adults under 20 years of age because of the risk of adverse effects - severe intractable vomiting of known cause - vomiting associated with radiation therapy or intolerance to cytotoxic drugs. - assist in small bowel intubation

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.98 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium chloride; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. prevention and treatment of post-operative nausea and vomiting.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: glycerol; sodium hydroxide; ascorbyl palmitate; egg lecithin; sodium oleate; water for injections - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil; olive oil - injection, intravenous infusion - excipient ingredients: water for injections; egg lecithin; ascorbyl palmitate; sodium hydroxide; glycerol; sodium oleate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: sodium hydroxide; ascorbyl palmitate; egg lecithin; water for injections; sodium oleate; glycerol - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: sodium hydroxide; ascorbyl palmitate; egg lecithin; water for injections; glycerol; sodium oleate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil; olive oil - injection, intravenous infusion - excipient ingredients: water for injections; egg lecithin; glycerol; sodium hydroxide; sodium oleate; ascorbyl palmitate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: ascorbyl palmitate; water for injections; egg lecithin; sodium oleate; glycerol; sodium hydroxide - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.